Top 20 Companies in Global Subdermal Contraceptive Implants Market Worldwide 2025: Market Research Report (2026–2035)

Description

According to a research report published by Spherical Insights & Consulting, the Global Subdermal Contraceptive Implants market Size is projected to grow from USD 1.20 billion in 2025 to USD 2.70 billion by 2035, at a CAGR of 7.65% during the forecast period 2026–2035. The global subdermal contraceptive implants market is expanding rapidly due to rising awareness of long-acting reversible contraception, increasing family planning initiatives, government support programs, higher unintended pregnancy rates, improved healthcare access, and growing preference for safe, effective, and low-maintenance birth control methods worldwide.

 

Introduction

The global subdermal contraceptive implants market refers to long-acting reversible contraceptive devices inserted under the skin that release hormones such as etonogestrel or levonorgestrel to prevent pregnancy over several years. These implants are typically made from polymer-based materials combined with progestin hormones, ensuring controlled and sustained drug delivery. They are widely used in applications such as family planning, birth control, and prevention of unintended pregnancies, particularly in hospitals, clinics, and reproductive health programs. Key market trends include increasing demand for long-acting reversible contraceptives (LARCs), technological advancements in implant design, improved biocompatibility, and the development of more user-friendly insertion systems, creating significant growth opportunities. Additionally, supportive government initiatives such as family planning programs (e.g., FP2020) and national reproductive health policies, along with pilot programs introducing implants in countries like India, are enhancing accessibility and driving market expansion globally.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global Subdermal Contraceptive Implants market.

 

Market Segmentation

 

Global Subdermal Contraceptive Implants Market Size, Share & Industry Analysis, By Type (Etonogestrel Implant, Levonorgestrel Implant, and Others), Application (Hospital, Clinic, and Research Facilities), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2026–2035

 

Global Subdermal Contraceptive Implants Market Size & Statistics

 

• The Market size of global Subdermal Contraceptive Implants was estimated to be worth USD 1.20 billion in 2025.
• The Market is Going to Expand at a CAGR of 7.65% between 2026 and 2035.
• The Size of global Subdermal Contraceptive Implants market is anticipated to reach USD 2.70 billion by 2035.
• North America is expected to generate the fastest demand during the forecast period in the global Subdermal Contraceptive Implants market.
• Asia Pacific is expected to grow the largest during the forecast period in the global Subdermal Contraceptive Implants market.

 

Regional growth and demand

 

Asia-Pacific is expected to generate fastest demand during the forecast period in the global Subdermal Contraceptive Implants market. Asia-Pacific is witnessing the fastest growth due to its large reproductive-age population, high unmet need for contraception, and rising government-backed family planning programs in countries like India and Indonesia. Increasing awareness, improving healthcare access in rural areas, and NGO support for affordable long-acting contraceptives further drive adoption across the region.

 

North America is expected to grow the largest during the forecast period in the global Subdermal Contraceptive Implants market. North America’s growth is driven by advanced healthcare infrastructure, high awareness of long-acting reversible contraceptives, and strong insurance coverage for birth control. Favorable government policies, widespread availability of skilled healthcare providers, and increasing preference for convenient, low-maintenance contraceptive methods further support market expansion in the region.

 

 

Top 10 trends in the global Subdermal Contraceptive Implants market

1. Rising demand for LARCs
2. Increasing family planning awareness
3. Technological advancements in implants
4. Minimally invasive procedures adoption
5. Government and NGO support programs
6. Expansion in emerging markets
7. Product innovation and pipeline development
8. Preference for low-maintenance contraception
9. Strategic partnerships and collaborations
10. Improved healthcare infrastructure

 

1. Rising demand for LARCs

Long-acting reversible contraceptives are gaining popularity due to their high effectiveness, long duration (3–5 years), and minimal user intervention. Women prefer implants over daily pills, reducing compliance issues and unintended pregnancies, which significantly boosts market demand globally.

 

2. Increasing family planning awareness

Growing awareness through education campaigns, digital platforms, and healthcare providers is encouraging more women to adopt modern contraceptive methods. This is especially evident in developing regions where awareness programs are reducing misconceptions and improving acceptance of subdermal implants.

 

3. Technological advancements in implants

Continuous innovation has led to smaller, more biocompatible, and longer-lasting implants with fewer side effects. Improved insertion devices and hormone delivery systems enhance safety and user comfort, making implants more appealing to both patients and healthcare professionals.

 

4. Minimally invasive procedures adoption

Subdermal implants require simple, quick insertion and removal procedures, often performed in outpatient settings. This minimally invasive nature reduces recovery time and increases patient convenience, contributing to higher adoption rates across various healthcare facilities.

 

5. Government and NGO support programs

Governments and organizations are promoting contraceptive use through subsidized programs, free distribution, and national family planning policies. Initiatives like awareness drives and rural healthcare outreach improve accessibility, especially in low-income regions, accelerating market growth.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global Subdermal Contraceptive Implants market.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in global Subdermal Contraceptive Implants market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 20 Companies Leading the Global Subdermal Contraceptive Implants market

1. Merck & Co., Inc.
2. Bayer AG
3. Shanghai Dahua Pharmaceutical Co., Ltd.
4. Organon & Co.
5. Pfizer Inc.
6. Novartis AG
7. Baxter International Inc.
8. Becton, Dickinson and Company
9. Gerresheimer AG
10. SCHOTT AG
11. Eli Lilly and Company
12. Teva Pharmaceutical Industries Ltd.
13. Viatris Inc.
14. Gedeon Richter Plc.
15. Cipla Limited
16. Lupin Limited
17. HLL Lifecare Limited
18. DKT WomanCare Global
19. Theramex
20. Exeltis Healthcare

 

1. Merck & Co., Inc.

Headquarters: Rahway, New Jersey, U.S.

Revenue (2025): USD 60+ billion.

Merck is a global pharmaceutical leader and a dominant player in subdermal contraceptive implants through its product Nexplanon. The company focuses on women’s health, innovative drug delivery systems, and large-scale global distribution. Its strong R&D capabilities, regulatory approvals, and presence in over 140 countries strengthen its leadership in long-acting reversible contraception.

 

2. Bayer AG

Headquarters: Leverkusen, Germany.

Revenue (2025): USD 50+ billion.

Bayer is a major contributor to the contraceptive implants market with products like Jadelle. The company emphasizes women’s healthcare, hormone-based contraceptives, and strategic collaborations. Its global footprint, continuous innovation, and partnerships for expanding contraceptive access enhance its competitive position in long-acting contraceptive solutions.

 

3. Shanghai Dahua Pharmaceutical Co., Ltd.

Headquarters: Shanghai, China.

Shanghai Dahua is a key manufacturer of cost-effective contraceptive implants, especially for emerging markets. The company focuses on large-scale production, affordability, and government-supported family planning programs, making it a crucial supplier in Asia and developing regions.

 

4. Organon & Co.

Headquarters: Jersey City, New Jersey, U.S.

Revenue (2025): ~USD 4.7 billion.

Organon specializes in women’s health and is a leading provider of contraceptive implants through Nexplanon (spun off from Merck). The company focuses on reproductive health solutions, global accessibility, and expanding its women’s health portfolio through innovation and partnerships.

 

5. Pfizer Inc.

Headquarters: New York, U.S.

Revenue (2025): USD 60+ billion.

Pfizer is a global biopharmaceutical leader with involvement in reproductive health and contraceptive solutions. The company leverages strong R&D, global manufacturing, and strategic collaborations to support women’s healthcare, contributing indirectly to the subdermal contraceptive implants market through related pharmaceutical innovations.

 

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global Subdermal Contraceptive Implants market.

 

Are you ready to discover more about the global Subdermal Contraceptive Implants market?

The report provides an in-depth analysis of the leading companies operating in the global Subdermal Contraceptive Implants market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

 

1. Merck & Co., Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT analysis

2. Bayer AG
3. Shanghai Dahua Pharmaceutical Co., Ltd.
4. Organon & Co.
5. Pfizer Inc.
6. Novartis AG
7. Baxter International Inc.
8. Becton, Dickinson and Company
9. Gerresheimer AG
10. Others

 

Conclusion

 

The global subdermal contraceptive implants market is poised for steady growth, driven by increasing awareness of long-acting reversible contraceptives, supportive government initiatives, and rising demand for effective and low-maintenance birth control solutions. Technological advancements and improved healthcare access further enhance market expansion. Regionally, Asia-Pacific is expected to witness the fastest growth due to unmet contraceptive needs and population dynamics, while North America maintains a strong market presence supported by advanced infrastructure and favorable policies. Additionally, the market remains moderately consolidated, with key players focusing on innovation, strategic collaborations, and global distribution to strengthen their competitive position.

 

Our Industry Reports: 

United States Facility Management Market Share, Forecasts to 2033
Nanotechnology In Packaging Market Trend, Report to 2033
Vaccine Contract Manufacturing Market: Size and Share To 2033
Construction Chemicals Market Size and Share To 2033

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter